Z
0.850
-0.01 (-1.16%)
| Penutupan Terdahulu | 0.860 |
| Buka | 0.888 |
| Jumlah Dagangan | 36,826 |
| Purata Dagangan (3B) | 43,617 |
| Modal Pasaran | 88,537,704 |
| Harga / Jualan (P/S) | 4.14 |
| Harga / Buku (P/B) | 9.00 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Jun 2024 |
| Margin Operasi (TTM) | -44,930.90% |
| EPS Cair (TTM) | -0.070 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -39.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.91% |
| Nisbah Semasa (MRQ) | 2.20 |
| Aliran Tunai Operasi (OCF TTM) | -7.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.94 M |
| Pulangan Atas Aset (ROA TTM) | -27.09% |
| Pulangan Atas Ekuiti (ROE TTM) | -47.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Zentek Ltd. | Bercampur | Bercampur |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -3.0 |
| Purata | 0.50 |
|
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 6.01% |
| % Dimiliki oleh Institusi | 1.45% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Aspect Partners, Llc | 30 Sep 2024 | 1,666 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Dec 2024 | Pengumuman | Zentek Provides Update on International Opportunities |
| 09 Dec 2024 | Pengumuman | Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price |
| 27 Nov 2024 | Pengumuman | ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence |
| 06 Nov 2024 | Pengumuman | Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology |
| 31 Oct 2024 | Pengumuman | Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters |
| 17 Oct 2024 | Pengumuman | Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |